Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis

Pierre Renaudin, Laurent Boyer (), Marie-Anne Esteve (), Pierre Bertault-Peres, Pascal Auquier () and Stéphane Honore ()
Additional contact information
Pierre Renaudin: TIMONE - Hôpital de la Timone [CHU - APHM]
Laurent Boyer: C3M - Centre méditerranéen de médecine moléculaire - UNS - Université Nice Sophia Antipolis (1965 - 2019) - INSERM - Institut National de la Santé et de la Recherche Médicale - UniCA - Université Côte d'Azur
Marie-Anne Esteve: CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie - AMU - Aix Marseille Université - TIMONE - Hôpital de la Timone [CHU - APHM] - INSERM - Institut National de la Santé et de la Recherche Médicale, Service Pharmacie [Hôpital de la Timone - APHM] - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille - TIMONE - Hôpital de la Timone [CHU - APHM]
Pierre Bertault-Peres: Service Pharmacie [Hôpital de la Timone - APHM] - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille - TIMONE - Hôpital de la Timone [CHU - APHM]
Pascal Auquier: SPMC - Santé Publique et maladies Chroniques : Qualité de vie Concepts, Usages et Limites, Déterminants - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille
Stéphane Honore: CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie - AMU - Aix Marseille Université - TIMONE - Hôpital de la Timone [CHU - APHM] - INSERM - Institut National de la Santé et de la Recherche Médicale, Service Pharmacie [Hôpital de la Timone - APHM] - AMU - Aix Marseille Université - APHM - Assistance Publique - Hôpitaux de Marseille - TIMONE - Hôpital de la Timone [CHU - APHM]

Post-Print from HAL

Abstract: AimsThe aim of this meta-analysis is to examine the impact of ă in-hospital pharmacist-led medication reviews in paediatric and adult ă patients. ă MethodsRelevant studies were identified from the Medline and Cochrane ă Library databases. Studies were included if they met the following ă criteria (without any language or date restrictions): design: randomized ă controlled trial; intervention: in-hospital pharmacist-led medication ă review (experimental group) vs. usual care (control group); ă participants: paediatric or adult population. The primary outcome was ă all-cause readmissions and/or emergency department (ED) visits at ă different time points. The secondary outcomes were all-cause ă readmissions, all-cause ED visits, drug-related readmissions, mortality, ă length of hospital stay, adherence and quality of life. We calculated ă the relative risk (RR) or mean differences (MD) with 95% confidence ă intervals (CIs) for each study. We used fixed and/or random effects ă models. Heterogeneity was assessed using the I-2 statistic. ă ResultsWe systematically reviewed 19 randomized controlled trials (4805 ă participants). The readmission rates did not differ between the ă experimental group and the control group (RR=0.97, 95% CI 0.89; 1.05, ă p=0.470). The secondary outcomes did not differ between the two groups, ă except for in drug-related readmissions, which were lower in the ă experimental group (RR=0.25, 95% CI 0.14; 0.45, p

Keywords: quality (search for similar items in EconPapers)
Date: 2016-12
References: Add references at CitEc
Citations:

Published in British Journal of Clinical Pharmacology, 2016, 82 (6), pp.1660-1673

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01482370

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().